The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
RecruitingOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
June 15, 2024
Primary Completion Date
March 31, 2028
Study Completion Date
May 31, 2029
Conditions
Peritoneal MetastasisGastric Cancer
Trial Locations (1)
200025
RECRUITING
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai
All Listed Sponsors
lead
Ruijin Hospital
OTHER
NCT06597526 - The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis. | Biotech Hunter | Biotech Hunter